FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1071-1073 March 8, 2007 Number 10 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Camenzind, E. Related Article by Scheller, B.

To the Editor: We question the conclusion by Scheller and colleagues (Nov. 16 issue)¹ that paclitaxel-coated balloon catheters significantly reduce the incidence of adverse outcomes in patients undergoing percutaneous coronary intervention for in-stent stenosis. First, the trial was reported to be a double-blind study, but the investigators were aware of assignments to study groups because the paclitaxel-coated balloons were a different color from the uncoated balloons. The reduction in major cardiac events in patients who received treatment with a paclitaxel-coated balloon was driven primarily by a reduction in target-lesion revascularization, a subjective end point that was based on symptoms and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.